About DIACOUSTIC MEDICAL DEVICES (PTY)
DIACOUSTIC MEDICAL DEVICES (PTY) Ltd. is a healthcare AI company that specializes in developing computer-aided diagnostic tools, particularly for cardiac auscultation. Their flagship product, SensiCardiac Mobi, is a decision support software designed to record, analyze, and interpret heart sounds captured by an electronic stethoscope. It assists clinicians in distinguishing between normal and pathological heart murmurs by identifying specific heart sounds like S1, S2, and various murmurs.
This technology aims to enhance the accuracy and efficiency of heart sound assessment, providing supportive information during clinical evaluations. The company’s innovations contribute to advancing medical imaging through artificial intelligence, offering a minimally invasive alternative to traditional diagnostic methods for certain conditions. DIACOUSTIC MEDICAL DEVICES (PTY) Ltd. received FDA clearance for its computer-aided diagnostic device in July 2011, highlighting its commitment to regulatory standards and product efficacy.
Focus Areas
Business Intelligence
| Technology | computer-aided auscultation device with AI for heart sound classification |
What Physicians Need to Know
Physicians can leverage DIACOUSTIC MEDICAL DEVICES (PTY)'s technology to enhance the accuracy and objectivity of heart sound auscultation, moving beyond subjective interpretations. The digital recording and analysis capabilities provide a robust tool for documenting patient conditions, tracking changes over time, and supporting referral decisions. The AI-powered decision support can assist in distinguishing between normal and pathological heart murmurs, potentially leading to earlier and more precise diagnoses. Furthermore, the telemedicine capabilities can facilitate remote consultations and specialist input, improving access to care. Integrating these devices into clinical workflows can streamline examinations and provide a comprehensive digital record of cardiac acoustic data.
DIACOUSTIC MEDICAL DEVICES (PTY)'s systems are designed to integrate with electronic stethoscopes and can transfer data via Bluetooth to laptops or smartphones. This suggests potential for integration with existing electronic health record (EHR) systems for seamless data storage and retrieval, though specific EHR integrations are not detailed. The use of software applications implies compatibility with standard operating systems. Further integration opportunities may exist with other diagnostic platforms and telemedicine solutions to create a more connected healthcare ecosystem.
What the Web Says
Information about DIACOUSTIC MEDICAL DEVICES (PTY) is limited across major review platforms like G2, Glassdoor, Capterra, and Reddit. While the company appears to be involved in medical devices, particularly in areas like radiology AI and electronic stethoscopes, there are no direct product or employer reviews available from the requested sources. General discussions on Reddit about the medical device industry highlight concerns about sales roles, pay, and the regulatory environment. Review sites like G2 and Capterra primarily offer reviews for other software and medical device companies, not DIACOUSTIC MEDICAL DEVICES (PTY) specifically.
Overall: MixedLimitations
No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.
Based on reviews from: RadAISlice, FDA, Google Patents, Proclinical Blogs, Indeed.com, Reddit, TrustRadius, G2, YouTube, HearWeb, Quora
Last updated: 2026-10-24
Videos
News, demos, and interviews about DIACOUSTIC MEDICAL DEVICES (PTY).
Videos load interactively. If none appear, search YouTube for DIACOUSTIC MEDICAL DEVICES (PTY) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]